Laurion Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-214,356
| Closed | -$2.35M | – | 465 |
|
|
2023
Q2 | $2.35M | Sell |
214,356
-1,707,747
| -89% | -$18.7M | 0.01% | 97 |
|
|
2023
Q1 | $16.8M | Buy |
1,922,103
+306,203
| +19% | +$2.67M | 0.11% | 35 |
|
|
2022
Q4 | $10.1M | Hold |
1,615,900
| – | – | 0.05% | 58 |
|
|
2022
Q3 | $5.66M | Buy |
1,615,900
+40,631
| +3% | +$142K | 0.03% | 83 |
|
|
2022
Q2 | $4.65M | Buy |
+1,575,269
| New | +$4.65M | 0.07% | 66 |
|
|
2018
Q2 | – | Sell |
-50,560
| Closed | -$657K | – | 1363 |
|
|
2018
Q1 | $657K | Buy |
+50,560
| New | +$657K | 0.01% | 678 |
|